Mario Frias

Dr. Mario Frias


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2018 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
Antonio Rivero-JuarezAntonio Rivero-Juarez
Antonio Rivero-Juarez
MRMaría A. Risalde
María A. Risalde
MFMario Frias
Mario Frias
IGIgnacio García-Bocanegra
Ignacio García-Bocanegra
PLPedro Lopez-Lopez
Pedro Lopez-Lopez
Antonio Rivero-JuarezAntonio Rivero-Juarez
Antonio Rivero-Juarez
It has been shown that wildlife can serve as natural reservoirs of hepatitis E virus (HEV). The wild boar (Sus scrofa) is probably the main natural reservoir of HEV and could therefore represent an important route of transmission in Europe, especially in regions where game meat is widely consumed. We evaluated the prevalence of HEV infection in wild boar in the south of Spain, with the aim of identifying associated risk factors. A cross-sectional study that included hunted wild boar was carried out during the 2015/2016 hunting season (October 15 to February 15) in Andalusia (southern Spain). The outcome variable was HEV infection, defined as amplification of HEV RNA in serum by RT-PCR. A total of 142 animals, selected from 12 hunting areas, were included and formed the study population. Thirty-three wild boars (23.2%; 95% CI: 16.8%–30.7%) were positive for HEV infection. Prevalence peaked in October and November, then gradually declined until the end of December. After multivariate analysis, only hunting date was independently associated with HEV infection across sex and age. Our study found a relatively high prevalence of HEV infection in wild boar in the south of Spain, suggesting that prevalence may depend on the season when the animal is hunted. In consequence, the potential risk of zoonotic transmission could fluctuate.

20 February 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CGCarmen Gasca-Capote
Carmen Gasca-Capote
XLXiaodong Lian
Xiaodong Lian
CGCe Gao
Ce Gao
IRIsabelle C. Roseto
Isabelle C. Roseto
MJMaría Reyes Jiménez-León
María Reyes Jiménez-León
EREzequiel Ruiz-Mateos
Ezequiel Ruiz-Mateos
BACKGROUND: Persistent controllers (PCs) maintain antiretroviral-free HIV-1 control indefinitely over time, while transient controllers (TCs) eventually lose virological control. It is essential to characterize the quality of the HIV reservoir in terms of these phenotypes in order to identify the factors that lead to HIV progression and to open new avenues toward an HIV cure. METHODS: The characterization of HIV-1 reservoir from peripheral blood mononuclear cells was performed using next-generation sequencing techniques, such as full-length individual and matched integration site proviral sequencing (FLIP-Seq; MIP-Seq). RESULTS: PCs and TCs, before losing virological control, presented significantly lower total, intact, and defective proviruses compared with those of participants on antiretroviral therapy (ART). No differences were found in total and defective proviruses between PCs and TCs. However, intact provirus levels were lower in PCs compared with TCs; indeed the intact/defective HIV-DNA ratio was significantly higher in TCs. Clonally expanded intact proviruses were found only in PCs and located in centromeric satellite DNA or zinc-finger genes, both associated with heterochromatin features. In contrast, sampled intact proviruses were located in permissive genic euchromatic positions in TCs. CONCLUSIONS: These results suggest the need for, and can give guidance to, the design of future research to identify a distinct proviral landscape that may be associated with the persistent control of HIV-1 without ART. FUNDING: Instituto de Salud Carlos III (FI17/00186, FI19/00083, MV20/00057, PI18/01532, PI19/01127 and PI22/01796), Gilead Fellowships (GLD22/00147). NIH grants AI155171, AI116228, AI078799, HL134539, DA047034, MH134823, amfAR ARCHE and the Bill and Melinda Gates Foundation.

26 December 2019 in Microorganisms
Verified
Journal Article
Open access
PDF file
Antonio Rivero-JuarezAntonio Rivero-Juarez
Antonio Rivero-Juarez
NVNicolau Vallejo
Nicolau Vallejo
PLPedro Lopez-Lopez
Pedro Lopez-Lopez
ADAna Isabel Díaz-Mareque
Ana Isabel Díaz-Mareque
MFMario Frias
Mario Frias
AAAntonio Aguilera
Antonio Aguilera
The hepatitis E virus (HEV) is the major cause of acute hepatitis of viral origin worldwide. Despite its usual course as an asymptomatic self-limited hepatitis, there are highly susceptible populations, such as those with underlying immunosuppression, which could develop chronic hepatitis. In this situation, implementation of therapy is mandatory in the sense to facilitate viral clearance. Currently, there are no specific drugs approved for HEV infection, but ribavirin (RBV), the drug of choice, is used for off-label treatment. Here, we present two cases of chronic HEV infection in transplant patients, reviewing and discussing the therapeutic approach available in the literature. The use of RBV for the treatment of an HEV infection in organ transplant patients seems to be effective. The recommendation of 12 weeks of therapy is adequate in terms of efficacy. Nevertheless, there are important issues that urgently need to be assessed, such as optimal duration of therapy and drug dosage.

26 November 2019 in Microorganisms
Verified
Journal Article
Open access
PDF file
PLPedro Lopez-Lopez
Pedro Lopez-Lopez
MFMario Frias
Mario Frias
ACAngela Camacho
Angela Camacho
Antonio Rivero-JuarezAntonio Rivero-Juarez
Antonio Rivero-Juarez
Antonio Rivero-JuarezAntonio Rivero-Juarez
Antonio Rivero-Juarez
Hepatitis E virus (HEV) infection is the most common cause of acute hepatitis in the world. It is not well established whether people infected with the human immunodeficiency virus (HIV) are more susceptible to infection with HEV than people not infected with HIV. Many studies have evaluated this relationship, although none are conclusive. The aim of this systematic review and meta-analysis was to assess whether patients with HIV infection constitute a risk group for HEV infection. A systematic review and meta-analysis was performed in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), to find publications comparing HEV seroprevalences among HIV infected and uninfected populations. The analysis was matched by sex, age and geographical area, and compared patients who live with HIV and HIV-negative individuals. The odds ratio (OR) for patients with HIV was 0.87 (95% CI: 0.74–1.03) in the fixed effects meta-analysis and 0.88 (95% CI: 0.70–1.11) in random effects, with I2 = 47%. This study did not show that HIV infection was a risk factor for HEV infection when compared with those who are HIV-negative.

29 April 2022 in BMC Zoology
Verified
Journal Article
Open access
PDF file
LCLaia Casades-Martí
Laia Casades-Martí
MFMario Frias
Mario Frias
SDSarah Delacour
Sarah Delacour
FRFrancisco Ruiz-Fons
Francisco Ruiz-Fons
Background: The ‘snow-melt mosquito’ aedes (rusticoidus) refiki is a rare species with a wide distribution in Europe that is usually defined as an aggressive mosquito for mammals, including humans. During a mosquito survey in a peri-urban area in south-central mainland Spain, adult Ae. refiki females were captured and identified by morphological traits. The presence of this species of mosquito has never been molecularly confirmed under continental dry Mediterranean climatic influence with scarce number of days with snow on soil. The aim of this study was to confirm by amplification and sequencing of mitochondrial cytochrome c oxidase subunit I (COI) and internal transcribed spacer 2 (ITS2) region. Results: We also successfully amplified and typed the species molecularly by COI and ITS2 regions. The peri-urban area where Ae. refiki was found contrasts with the reported cold, humid and snowy environments required by the species to breed. Conclusions: This finding suggests that the species is already adapted to continental dry Mediterranean environments, questioning whether it is a truly stenotopic species of cold snowy environments.

23 April 2026 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PDF file
Ehab Kotb ElmahallawyEhab Kotb Elmahallawy
Ehab Kotb Elmahallawy
Ehab Kotb ElmahallawyEhab Kotb Elmahallawy
Ehab Kotb Elmahallawy
MFMario Frias
Mario Frias
WAWejdan Oudah Albalawi
Wejdan Oudah Albalawi
SESamar A. Eissa
Samar A. Eissa
IGIgnacio García-Bocanegra
Ignacio García-Bocanegra
Crimean-Congo hemorrhagic fever virus (CCHFV) is recognized as one of the most severe zoonotic viruses, marked by gastrointestinal disturbances and hemorrhagic symptoms in its more severe forms. Transmission occurs mainly through ticks of the genus Hyalomma or through contact with infected animal tissues. A wide range of animals can be asymptomatically infected, and the presence of antibodies against CCHFV in these animals poses a significant risk to individuals who are in close contact with livestock. Globally, research on CCHFV is scarce, and this is particularly true in the case of Egypt. This study aimed to evaluate the exposure of camels to CCHFV in Egypt and to compare seroprevalence across different geographic regions. In this investigation, a total of 513 serum samples were collected from apparently healthy camels across Egypt, representing the key northern and southern parts of the country, and tested using an enzyme-linked immunosorbent assay (ELISA). Surprisingly, a total of 511 samples (99.61%) tested positive for CCHFV antibodies, representing the highest seroprevalence rate of CCHFV reported at both national and international levels. Seropositivity was consistently observed across all sampled regions. The observed high seroprevalence indicates frequent exposure of camels in Egypt to CCHFV or antigenically related viruses. Camels may therefore represent an important component of viral circulation among livestock populations. Given the close contact between camels and humans during husbandry, transport, and slaughter, these findings support the need for improved surveillance at the camel-human interface. In conclusion, this study provides interesting serological evidence of widespread exposure of camels to CCHFV in Egypt. Further large-scale serological and molecular investigations in livestock and humans, together with the characterization of circulating viral strains and assessment of tick infestation, are required to better define CCHFV transmission dynamics and potential implications for human health.